TY - JOUR
T1 - Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis
AU - Huisjes, Rick
AU - Mahkro, A
AU - Llaudet-Planas, Esther
AU - Hertz, L
AU - Petkova-Kirova, P
AU - Verhagen, LP
AU - Pignatelli, Silvia
AU - Rab, MAE
AU - Schiffelers, Raymond
AU - Seiler, E
AU - van Solinge, W.W.
AU - Vives-Corrons, J.-L.
AU - Mañu-Pereira, Maria del Mar
AU - Kaestner, Lars
AU - Bogdanova, Anna
AU - van Wijk, Richard
N1 - Funding Information:
Funding for the research leading to these results was received from the European Seventh Framework Program under grant agreement number 602121 (CoMMiTMenT) and from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement number 675115 - RELEVANCE - H2020-MSCA-ITN-2015/H2020-MSCA-ITN- 2015. This work was generated within the European Reference Network on Rare Hematological Diseases (ERNEuroBloodNet)- FPA No. 739541
Funding Information:
Funding for the research leading to these results was received from the European Seventh Framework Program under grant agreement number 602121 (CoMMiTMenT) and from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement number 675115 — RELEVANCE — H2020-MSCA-ITN-2015/H2020-MSCA-ITN-2015. This work was generated within the European Reference Network on Rare Hematological Diseases (ERN-EuroBloodNet) – FPA No. 739541
Publisher Copyright:
© 2020 Ferrata Storti Foundation.
PY - 2020/1/31
Y1 - 2020/1/31
N2 - Hereditary spherocytosis (HS) originates from defective anchoring of the cytoskeletal network to the transmembrane protein complexes of the red blood cell (RBC). Red cells in HS are characterized by membrane instability and reduced deformability and there is marked heterogeneity in disease severity among patients. To unravel this variability in disease severity, we analyzed blood samples from 21 HS patients with defects in ankyrin, band 3, á-spectrin or β-spectrin using red cell indices, eosin-5- maleimide binding, microscopy, the osmotic fragility test, Percoll density gradients, vesiculation and ektacytometry to assess cell membrane stability, cellular density and deformability. Reticulocyte counts, CD71 abundance, band 4.1 a:b ratio, and glycated hemoglobin were used as markers of RBC turnover. We observed that patients with moderate/severe spherocytosis have short-living erythrocytes of low density and abnormally high intercellular heterogeneity. These cells show a prominent decrease in membrane stability and deformability and, as a consequence, are quickly removed from the circulation by the spleen. In contrast, in mild spherocytosis less pronounced reduction in deformability results in prolonged RBC lifespan and, hence, cells are subject to progressive loss of membrane. RBC from patients with mild spherocytosis thus become denser before they are taken up by the spleen. Based on our findings, we conclude that RBC membrane loss, cellular heterogeneity and density are strong markers of clinical severity in spherocytosis.
AB - Hereditary spherocytosis (HS) originates from defective anchoring of the cytoskeletal network to the transmembrane protein complexes of the red blood cell (RBC). Red cells in HS are characterized by membrane instability and reduced deformability and there is marked heterogeneity in disease severity among patients. To unravel this variability in disease severity, we analyzed blood samples from 21 HS patients with defects in ankyrin, band 3, á-spectrin or β-spectrin using red cell indices, eosin-5- maleimide binding, microscopy, the osmotic fragility test, Percoll density gradients, vesiculation and ektacytometry to assess cell membrane stability, cellular density and deformability. Reticulocyte counts, CD71 abundance, band 4.1 a:b ratio, and glycated hemoglobin were used as markers of RBC turnover. We observed that patients with moderate/severe spherocytosis have short-living erythrocytes of low density and abnormally high intercellular heterogeneity. These cells show a prominent decrease in membrane stability and deformability and, as a consequence, are quickly removed from the circulation by the spleen. In contrast, in mild spherocytosis less pronounced reduction in deformability results in prolonged RBC lifespan and, hence, cells are subject to progressive loss of membrane. RBC from patients with mild spherocytosis thus become denser before they are taken up by the spleen. Based on our findings, we conclude that RBC membrane loss, cellular heterogeneity and density are strong markers of clinical severity in spherocytosis.
UR - http://www.scopus.com/inward/record.url?scp=85078815514&partnerID=8YFLogxK
U2 - 10.3324/haematol.2018.188151
DO - 10.3324/haematol.2018.188151
M3 - Article
C2 - 31147440
SN - 0390-6078
VL - 105
SP - 338
EP - 347
JO - Haematologica
JF - Haematologica
IS - 2
ER -